Nutex Health Inc. (NUTX)
NASDAQ: NUTX
· Real-Time Price · USD
90.30
-20.83 (-18.74%)
At close: Aug 15, 2025, 10:04 AM
-18.74% (1D)
| Bid | n/a |
| Market Cap | 501.63M |
| Revenue (ttm) | 624.28M |
| Net Income (ttm) | 96.77M |
| EPS (ttm) | 12.35 |
| PE Ratio (ttm) | 7.31 |
| Forward PE | 7.43 |
| Analyst | Strong Buy |
| Ask | n/a |
| Volume | 112,015 |
| Avg. Volume (20D) | 235,791 |
| Open | 108.00 |
| Previous Close | 111.13 |
| Day's Range | 90.00 - 108.00 |
| 52-Week Range | 13.06 - 184.28 |
| Beta | 1.94 |
About NUTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NUTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NUTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Nutex Health Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+26.1%
Nutex Health shares are trading higher after the c...
Unlock content with
Pro Subscription
4 months ago
+51.82%
Nutex Health shares are trading higher after the company reported better-than-expected FY24 revenue results.
1 month ago · seekingalpha.com
Nutex Health: Justified Dilution Given Explosive Growth In Free Cash FlowNutex Health delivered a blowout Q1 2025, with $51M in free cash flow and 214% y/y revenue growth, driven by arbitration wins. A frank discussion of its equity dilution. The company's growth is impres...
2 months ago · seekingalpha.com
Nutex Health Inc.: High-Growth Healthcare Innovator With Strong MomentumNUTX is transforming from a turnaround story to a high-growth, high-risk play, driven by explosive revenue and profitability from its micro-hospital model. The company's financials show triple-digit r...